1. Home
  2. ORRF vs CSTL Comparison

ORRF vs CSTL Comparison

Compare ORRF & CSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ORRF
  • CSTL
  • Stock Information
  • Founded
  • ORRF 1919
  • CSTL 2007
  • Country
  • ORRF United States
  • CSTL United States
  • Employees
  • ORRF N/A
  • CSTL N/A
  • Industry
  • ORRF Major Banks
  • CSTL Medical Specialities
  • Sector
  • ORRF Finance
  • CSTL Health Care
  • Exchange
  • ORRF Nasdaq
  • CSTL Nasdaq
  • Market Cap
  • ORRF 608.7M
  • CSTL 561.9M
  • IPO Year
  • ORRF N/A
  • CSTL 2019
  • Fundamental
  • Price
  • ORRF $34.06
  • CSTL $16.31
  • Analyst Decision
  • ORRF Buy
  • CSTL Strong Buy
  • Analyst Count
  • ORRF 2
  • CSTL 6
  • Target Price
  • ORRF $39.00
  • CSTL $37.67
  • AVG Volume (30 Days)
  • ORRF 155.9K
  • CSTL 412.8K
  • Earning Date
  • ORRF 07-22-2025
  • CSTL 08-04-2025
  • Dividend Yield
  • ORRF 3.10%
  • CSTL N/A
  • EPS Growth
  • ORRF N/A
  • CSTL N/A
  • EPS
  • ORRF 1.84
  • CSTL N/A
  • Revenue
  • ORRF $203,869,000.00
  • CSTL $347,083,000.00
  • Revenue This Year
  • ORRF $15.80
  • CSTL N/A
  • Revenue Next Year
  • ORRF $3.45
  • CSTL $1.36
  • P/E Ratio
  • ORRF $18.20
  • CSTL N/A
  • Revenue Growth
  • ORRF 56.29
  • CSTL 38.43
  • 52 Week Low
  • ORRF $25.57
  • CSTL $15.45
  • 52 Week High
  • ORRF $41.99
  • CSTL $35.84
  • Technical
  • Relative Strength Index (RSI)
  • ORRF 63.56
  • CSTL 32.55
  • Support Level
  • ORRF $33.45
  • CSTL $16.25
  • Resistance Level
  • ORRF $34.05
  • CSTL $20.26
  • Average True Range (ATR)
  • ORRF 0.59
  • CSTL 0.75
  • MACD
  • ORRF -0.05
  • CSTL -0.45
  • Stochastic Oscillator
  • ORRF 62.15
  • CSTL 11.82

About ORRF Orrstown Financial Services Inc

Orrstown Financial Services Inc is a holding company engaged in commercial banking and trust business, this involves accepting demand, time, and savings deposits and granting loans. The company is also engaged in lending services for commercial, residential, commercial mortgages, construction, municipal, and various forms of consumer lending, and deposit services that include checking, savings, time, and money market deposits. It also provides investment and brokerage services through its Financial Advisors division. The Company earns fees from its deposit clients for transaction-based account maintenance and overdraft services, It also earns wealth management and investment brokerage fees from its contracts with trusts. The company operates in a segment, namely Community Banking.

About CSTL Castle Biosciences Inc.

Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. It also provides DecisionDx-UM, a risk stratification GEP test. The company also offers its products to the skin cancer and gastroenterology markets.

Share on Social Networks: